Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00023439 · ClinicalTrials.gov registry record
TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment
A clinical trial, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- 300
- Enrollment target
NCT00023439 is a clinical trial that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 300 participants.
The verdict
NCT00023439 has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
This is a pilot study to evaluate the performance of several nucleic acid amplification methodologies in the diagnosis and management of active tuberculosis
Interventions
- OTHER Nucleic Acid Amplification Methods for diagnosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2000-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00023439
The ClinicalTrials.gov registry entry for NCT00023439 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nucleic Acid Amplification Methods for diagnosis is the first listed.
NCT00023439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00023439 about?
NCT00023439 is a clinical study titled "TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment". This is a pilot study to evaluate the performance of several nucleic acid amplification methodologies in the diagnosis and management of active tuberculosis
What is the current status of trial NCT00023439?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2000-05.
What interventions are being tested in trial NCT00023439?
The interventions under investigation include: Nucleic Acid Amplification Methods for diagnosis (OTHER).
Who is sponsoring clinical trial NCT00023439?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.